Nabriva Therapeutics PLC at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Good day, everybody. Thank you for joining us at the Bank of America Annual Health Care Conference. My name is Jason Gerberry, and I cover specialty pharma and biotech at BofA, and I'm pleased to be introducing our next company presenter, Nabriva Therapeutics and CEO, Ted Schroeder.
Nabriva is a development-stage and commercial-stage biotech with a portfolio -- with a lead asset in the antibiotic space. And Ted has a company presentation that he's going to walk you through.
So I'm going to hand it over to Ted.
Well, thank you, Jason, and good morning to everyone, who's joined us on the call. I appreciate your interest in Nabriva and what we're building here.
Start off, just draw your attention to the safe harbor statement. And to remind you that the risks associated with Nabriva are fully described in our various SEC filings and available on our website.
So moving on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
